insulin aspart

Generic: insulin aspart

Labeler: novo nordisk pharma, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name insulin aspart
Generic Name insulin aspart
Labeler novo nordisk pharma, inc.
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS SUBCUTANEOUS
Active Ingredients

insulin aspart 100 [iU]/mL

Manufacturer
Novo Nordisk Pharma, Inc.

Identifiers & Regulatory

Product NDC 73070-103
Product ID 73070-103_393af9a3-df9a-40b2-a5e6-bfa5434a2552
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA020986
Listing Expiration 2026-12-31
Marketing Start 2003-01-22

Pharmacologic Class

Established (EPC)
insulin analog [epc]
Chemical Structure
insulin [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 73070103
Hyphenated Format 73070-103

Supplemental Identifiers

RxCUI
311040 1653196 1653202
UNII
D933668QVX
NUI
M0011417 N0000175453

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name insulin aspart (source: ndc)
Generic Name insulin aspart (source: ndc)
Application Number BLA020986 (source: ndc)
Routes
INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 100 [iU]/mL
source: ndc
Packaging
  • 5 SYRINGE, PLASTIC in 1 CARTON (73070-103-15) / 3 mL in 1 SYRINGE, PLASTIC (73070-103-10)
source: ndc

Packages (1)

73070-103-15 5 SYRINGE, PLASTIC in 1 CARTON (73070-103-15) / 3 mL in 1 SYRINGE, PLASTIC (73070-103-10)

Ingredients (1)

insulin aspart (100 [iU]/mL)

Linked Drug Pages (1)

Insulin Aspart ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "393af9a3-df9a-40b2-a5e6-bfa5434a2552", "openfda": {"nui": ["M0011417", "N0000175453"], "unii": ["D933668QVX"], "rxcui": ["311040", "1653196", "1653202"], "spl_set_id": ["bee5b358-c863-420b-be73-ced2e920c499"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "manufacturer_name": ["Novo Nordisk Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 SYRINGE, PLASTIC in 1 CARTON (73070-103-15)  / 3 mL in 1 SYRINGE, PLASTIC (73070-103-10)", "package_ndc": "73070-103-15", "marketing_start_date": "20190910"}], "brand_name": "Insulin Aspart", "product_id": "73070-103_393af9a3-df9a-40b2-a5e6-bfa5434a2552", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Insulin Analog [EPC]", "Insulin [CS]"], "product_ndc": "73070-103", "generic_name": "insulin aspart", "labeler_name": "Novo Nordisk Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Insulin Aspart", "active_ingredients": [{"name": "INSULIN ASPART", "strength": "100 [iU]/mL"}], "application_number": "BLA020986", "marketing_category": "BLA", "marketing_start_date": "20030122", "listing_expiration_date": "20261231"}